Search

Your search keyword '"Olopade, O.I."' showing total 147 results

Search Constraints

Start Over You searched for: Author "Olopade, O.I." Remove constraint Author: "Olopade, O.I."
147 results on '"Olopade, O.I."'

Search Results

1. Evaluation of a Graphic Narrative Patient Education Tool to Reduce Pre-Treatment Anxiety for Patients Receiving Radiotherapy in a Latin American Hospital

2. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

3. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

10. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

11. Ethics and Responsible Conduct of Research: Workshop Report

12. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

13. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

14. Two truncating variants in FANCC and breast cancer risk.

15. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

16. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

17. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

18. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

19. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

20. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

21. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

22. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

23. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

24. Two truncating variants in FANCC and breast cancer risk

25. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

26. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

27. Shared heritability and functional enrichment across six solid cancers.

28. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

29. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

30. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

32. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

33. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

35. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

36. Survivorship patterns of histopathological variants and molecular subtypes of breast cancer in a teaching hospital in Nigeria

37. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

40. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

41. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

42. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

43. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

45. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

46. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

47. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

48. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

49. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

50. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Catalog

Books, media, physical & digital resources